Back to top

Atara gets FDA priority review for Tabelecleucel application

Atara gets FDA priority review for Tabelecleucel application

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Atara Biotherapeutics, Inc. (ATRA)